Skip to main content
. 2019 Sep 3;10:2095. doi: 10.3389/fimmu.2019.02095

Figure 3.

Figure 3

Effects of WKYMVm treatment on myofibroblast differentiation in scleroderma. (A) WKYMVm-induced inhibition of myofibroblast differentiation in scleroderma. The BLM-induced scleroderma mice were treated with or without 1 μM Wm for 3 weeks, and the mock-treated (PBS) and the scleroderma (BLM or BLM + Wm) skin specimens were immunostained with antibodies against α-SMA and ILB-4. (B) The skin specimens were stained with antibodies against Vimentin and phospho-SMAD3. Scale bar = 50 μm. The numbers of α-SMA+ILB-4 (C), Vimentin+ (D), and Vimentin+phospho-SMAD3+ (E) cells were quantified under a high-power field. Data represent mean ± SD (n = 8 per group). *p < 0.05, **p < 0.01, ***p < 0.001.